Active Government Funding Opportunities

This RFP seeks an AI/ML-enabled portable troubleshooting device for military airborne optical networks, capable of centimeter-level fault detection across fiber-optic avionics systems. The solution must reduce aircraft downtime and maintenance burden by providing faster, more precise diagnostics than traditional equipment while supporting field technicians across diverse operational conditions.

This RFP seeks a shelf-stable canine whole blood product or substitute to improve Military Working Dog survival rates in combat. The solution must safely treat traumatic blood loss in operational environments with shelf-life exceeding three years and thermal stability across extreme temperatures.

Technology licensing opportunity for AddiSteel HT: additively manufactured Grade 91 ferritic steel with enhanced high-temperature performance. Patented 3D-printing process delivers 85% higher strength at 600°C.

NOAA seeks regional science teams to help states and communities understand and prepare for climate and weather hazards like flooding, extreme temperatures, and wildfires. Teams will conduct integrated research and partner with local decision-makers to improve resilience and preparedness across nine U.S. regions.

Supports early-stage, high-risk lung cancer research with potential for breakthrough discoveries. Designed for conceptually innovative projects, including a dedicated track for new faculty investigators seeking transformative advances.

The Army seeks patient-centered research to advance burn treatment and recovery outcomes for military personnel. This funding supports innovative clinical studies and therapeutic approaches to improve care for burn-injured soldiers.

This DoD grant funds exploratory research into tuberous sclerosis complex treatments, welcoming high-risk, innovative concepts without requiring preliminary data. It supports early-stage hypothesis development to advance breakthrough therapeutic approaches.

This DoD program funds innovative research into tuberous sclerosis complex (TSC) to drive critical discoveries and improve patient care. It welcomes both established researchers and investigators new to the TSC field, with separate competitive tracks.

This DoD award supports clinical translational research to advance tuberous sclerosis complex diagnosis, prognosis, and treatments from promising preclinical findings toward real-world clinical application. Multi-PI teams can collaborate on moving TSC research closer to patient care.

The Army seeks innovative technologies and therapeutic approaches to treat severe burn injuries in military personnel. This award funds development of novel burn treatment solutions from basic research through clinical application.

The Army seeks research ideas to advance understanding and countermeasures for tick-borne diseases affecting military readiness. This program supports early-stage scientific investigations to develop novel prevention, diagnosis, or treatment solutions.

The Army seeks translational research advancing vision science and optical technologies for military applications. This opportunity funds development of novel vision-related capabilities to bridge fundamental research and field-deployable solutions.

This Army Medical Research Acquisition Activity award supports mentored clinical research in vision-related medical challenges. It aims to develop clinical solutions and advance vision care capabilities through structured mentorship and research training.

This DoD program funds clinical trials for multiple sclerosis treatments, from early-stage proof-of-concept to phase 2 studies. It supports testing of new drugs, biologics, devices, and emerging technologies to improve MS management.

Supports investigator-led spinal cord injury research across basic to translational science phases. Aims to advance SCI patient care, treatment outcomes, and quality of life through competitive grants.

This DoD funding supports clinical trials testing new spinal cord injury treatments with potential to significantly improve patient outcomes. The program welcomes early-career researchers and requires community partnership to ensure research relevance.

This DoD funding supports early-stage lupus research planning, pilot studies, and phase 0/1 clinical trials to generate preliminary data and demonstrate feasibility for future interventional studies. Awards must include patient advocates and address FY26 lupus research priorities.

This DoD funding supports clinical translation research to move spinal cord injury treatments from preliminary studies into larger clinical trials. It prioritizes removing barriers to clinical success and identifying effective diagnosis, treatment, and rehabilitation options.

This DoD funding accelerates spinal cord injury research from promising ideas to clinical applications through translational research. It supports early-career partnerships and requires community engagement to ensure real-world relevance.

DoD seeks innovative, high-risk lupus research addressing critical gaps in disease understanding and treatment. Early-career researchers can propose novel ideas with or without preliminary data, emphasizing breakthrough discoveries over incremental advances.

Support innovative, high-risk MS research concepts at early exploration stages through hypothesis development. This award funds groundbreaking studies that establish foundations for future scientific investigation, with no preliminary data required.

This DoD funding supports high-risk, high-reward lupus research with potential for major scientific impact. Researchers can pursue innovative approaches addressing priority focus areas without requiring preliminary data.

Support early-stage researchers investigating Multiple Sclerosis through independent, mentor-guided projects. This award develops the next generation of MS researchers by funding novel research questions and advancing scientific careers in neuroimmunology.

DoD seeks interventional lupus research with near-term health impact, including clinical trials and health system innovations. Teams must include patient advocates and provide preliminary data demonstrating feasibility and potential quality-of-life improvements.

Support rigorous, investigator-initiated research projects advancing Multiple Sclerosis understanding and patient outcomes. Funding available for laboratory, clinical, and population-based studies with preliminary data, including dedicated tracks for early-career investigators.